乳腺癌。治疗进展。 - Suppr

Suppr

超能文献

Breast cancer. Advances in management.

作者信息

Brodie G N, Elefanty A

机构信息

Department of Medical Oncology, Prince Henry's Hospital, Melbourne.

出版信息

Drugs. 1988 May;35(5):584-95. doi: 10.2165/00003495-198835050-00006.

DOI:10.2165/00003495-198835050-00006

PMID:3293971

Abstract

摘要

相似文献

Breast cancer. Advances in management.乳腺癌。治疗进展。

Drugs. 1988 May;35(5):584-95. doi: 10.2165/00003495-198835050-00006.

Breast cancer: guidelines for modern management.乳腺癌：现代治疗指南

J Med Liban. 1994;42(1):17-22; discussion 23-4.

Breast cancer management: recent advances and recommendations.乳腺癌治疗：最新进展与建议

Adv Intern Med. 1984;29:215-44.

Breast cancer management in the nineteen nineties.20世纪90年代的乳腺癌治疗

R I Med. 1992 Jan;75(1):21-9.

Treatment of breast cancer.

Clin Symp. 1997;49(1):1-32.

Sarcomas of the Breast.乳房肉瘤。

Surg Clin North Am. 2018 Aug;98(4):869-876. doi: 10.1016/j.suc.2018.03.013. Epub 2018 May 21.

Breast cancer.乳腺癌

RN. 2000 Apr;63(4):40-5; quiz 48.

[Breast cancer. Text of recommendations. National Association of Accreditation and Health Evaluation].[乳腺癌。推荐文本。国家认证与健康评估协会]

J Radiol. 2000 Mar;81(3):269-80.

Inflammatory breast cancer.炎性乳腺癌

Clin J Oncol Nurs. 2001 Jul-Aug;5(4):175-6.

Breast cancer update. Part II: diagnosis and early treatment.乳腺癌最新进展。第二部分：诊断与早期治疗。

Harv Womens Health Watch. 2000 Nov;8(3):4-6.

引用本文的文献

Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.伊达比星。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。

Drugs. 1991 Oct;42(4):690-719. doi: 10.2165/00003495-199142040-00010.

Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.米托蒽醌。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。

Drugs. 1991 Mar;41(3):400-49. doi: 10.2165/00003495-199141030-00007.

本文引用的文献

Dose-response effect of adjuvant chemotherapy in breast cancer.辅助化疗在乳腺癌中的剂量反应效应。

N Engl J Med. 1981 Jan 1;304(1):10-5. doi: 10.1056/NEJM198101013040103.

The epidemiology and etiology of breast cancer.乳腺癌的流行病学与病因学

N Engl J Med. 1980 Nov 20;303(21):1246-8. doi: 10.1056/NEJM198011203032130.

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure.国家乳腺癌手术辅助治疗项目（协议号4）的病理研究结果。VI. 五年治疗失败的判别因素。

Cancer. 1980 Aug 15;46(4 Suppl):908-18. doi: 10.1002/1097-0142(19800815)46:4+<908::aid-cncr2820461310>3.0.co;2-5.

Low-dose radiation--a cause of breast cancer?低剂量辐射——乳腺癌的一个病因？

Cancer. 1980 Aug 15;46(4 Suppl):868-73. doi: 10.1002/1097-0142(19800815)46:4+<868::aid-cncr2820461304>3.0.co;2-s.

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.比较乳腺癌小肿瘤患者行根治性乳房切除术与象限切除术、腋窝淋巴结清扫术及放射治疗的效果。

N Engl J Med. 1981 Jul 2;305(1):6-11. doi: 10.1056/NEJM198107023050102.

Ten- to fourteen-year effect of screening on breast cancer mortality.筛查对乳腺癌死亡率的10至14年影响。

J Natl Cancer Inst. 1982 Aug;69(2):349-55.

Progesterone receptors as a prognostic factor in Stage II breast cancer.孕激素受体作为II期乳腺癌的一个预后因素

N Engl J Med. 1983 Dec 1;309(22):1343-7. doi: 10.1056/nejm198312013092240.

Cosmetic results following primary radiation therapy for early breast cancer.早期乳腺癌初次放射治疗后的美容效果。

Cancer. 1984 Dec 15;54(12):2911-8. doi: 10.1002/1097-0142(19841215)54:12<2911::aid-cncr2820541216>3.0.co;2-v.

T3b-T4 breast cancer: factors affecting results in combined modality treatments.

Clin Exp Metastasis. 1983 Apr-Jun;1(2):191-202. doi: 10.1007/BF00121498.

Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy.宏观直径在20毫米及以下的乳腺癌肿瘤：保守治疗与乳房切除术的对比。古斯塔夫 - 鲁西研究所的经验

Cancer. 1984 Mar 1;53(5):1209-13. doi: 10.1002/1097-0142(19840301)53:5<1209::aid-cncr2820530531>3.0.co;2-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验